Login
Login
APHRC Online Microdata Library
Home
About APHRC
Datasets
Collections
Citations
Resources
How to use it?
Why sharing data?
Contact us
Home
/
Central Data Catalog
/
HEALTH_AND_WELL-BEING
/
DDI-ETH-APHRC-BAOBAB-2023-V1.0
Measuring Abortion Incidence, Severity of Complications, and Health Facilities’ Capacity to Provide Abortion Care in Refugee Settings in Ethiopia, Baobab Study
Ethiopia,
,
2024
Health and Well-Being (HaW)
Yohannes Wado
Study description
Documentation
Data Description
Get Microdata
Data files
Baobab_Ethiopia_HFS_RECAST
Baobab_Ethiopia_PMS_MRR_RECAST
Baobab_Ethiopia_KIS_RECAST
Baobab_Ethiopia_PMS_Patient_Provider_Recast
Variable Groups
HFS
INTRODUCTION: INTERVIEW DETAILS
SECTION 1: GENERAL FACILITY QUESTIONS
SECTION 2: AVAILABILITY OF PAC SERVICES
SECTION 3: AVAILABILITY OF LEGAL SAFE ABORTION CARE SERVICES
SECTION 4: ABORTION COMPLICATION CASELOADS
SECTION 5: CONTRACEPTIVE COUNSELING AND PROVISION
SECTION 6: SERVICES FOR SPECIFIC POPULATIONS
SECTION 7: KNOWLEDGE AND ATTITUDES TOWARDS ABORTION
SECTION 8: AVAILABILITY OF EQUIPMENT
PMS_MRR
Introduction
INTERVIEW DETAILS
Section 1: Patient’s Medical Assessment
Section B: Laboratory Findings
Section C: Assessment of Complication Severity
Section D: Management
Section E: Outcomes
KIS
INTERVIEW DETAILS
SECTION 1: BACKGROUND
SECTION 2: GENERAL QUESTIONS
SECTION 3: INDUCED ABORTIONS
SECTION 5: A. ANSWER CERTAINTY
SECTION 6: STIGMA QUESTIONS
PMS_Patient Interview
PMS PATIENT SECTION
Introduction
SECTION 1: BASIC INFORMATION
SECTION 2: REPRODUCTIVE HEALTH HISTORY
SECTION 3: SYMPTOMS AND CARE-SEEKING DECISIONS
SECTION 4: QUALITY OF ABORTION AND FAMILY PLANNING SERVICES
SECTION 5: ABORTION KNOWLEDGE AND ATTITUDES
SECTION 6: SECURITY, CONFLICT AND VIOLENCE
PMS_PROVIDER SECTION
INTERVIEW DETAILS
Section 1: General Information on Patient Intake
Section 2: Initial Examination and Observations
Section 3: Complication Questions
Section 4: Procedures and Medications
Section 5: Likely Abortion Questions
Section 6: Final Outcome
Variable Groups
Variable group: Section C: Assessment of Complication Severity
Variables
97
c3_2
c3_98
c3_a
c4
c4_1
c4_2
c4_3
c4_4
c4_98
c4_a_1_spy
c4_a_2_spy
c4_a_4_spy
c4_b
c5
c6
c6_1
c6_2
c6_3
c6_98
c6a
c7
c8
c9
c10
c10_1
c10_2
c10_3
c10_4
c10_5
c10_6
c10_98
c10_a
c10_b_1a_spy
c10_b_1b_spy
c10_b_1c_spy
c10_b_3_spy
c10_b_4_spy
c10_b_5_spy
c11
c11_1
c11_2
c11_3
c11_4
c11_5
c11_6
c11_98
c11_a
c11_b
c12
c12_1
c12_2
c12_3
c12_98
c12_a
c12_b
c13
c13_1
c13_2
c13_3
c13_98
c13_a
c13b_2_spy
c13b_3_spy
c14
c14_1
c14_2
c14_98
c14_a
c14b_spy
c15
c15_1
c15_2
c15_3
c15_4
c15_98
c15_a
c16
c16_1
c16_2
c16_3
c16_98
c16_a
c1
c1_1
c1_2
c1_3
c1_98
c1_a
c2
c2_1
c2_2
c2_3
c2_4
c2_98
c2_a
c3
c3_1
